ArticlePDF Available

Identifying the ischaemic penumbra using pH-weighted magnetic resonance imaging

Authors:

Abstract and Figures

Harston et al. establish proof of principle for clinical use of pH-weighted MRI in patients with acute ischaemic stroke. Detailed tissue-level analysis reveals that cerebral intracellular pH, a marker of metabolic stress, is associated with eventual tissue outcome, and complements established imaging modalities.The original concept of the ischaemic penumbra suggested imaging of regional cerebral blood flow and metabolism would be required to identify tissue that may benefit from intervention. Amide proton transfer magnetic resonance imaging, a chemical exchange saturation transfer technique, has been used to derive cerebral intracellular pH in preclinical stroke models and has been proposed as a metabolic marker of ischaemic penumbra. In this proof of principle clinical study, we explored the potential of this pH-weighted magnetic resonance imaging technique at tissue-level. Detailed voxel-wise analysis was performed on data from a prospective cohort of 12 patients with acute ischaemic stroke. Voxels within ischaemic core had a more severe intracellular acidosis than hypoperfused tissue recruited to the final infarct (P < 0.0001), which in turn was more acidotic than hypoperfused tissue that survived (P < 0.0001). In addition, when confined to the grey matter perfusion deficit, intracellular pH (P < 0.0001), but not cerebral blood flow (P = 0.31), differed between tissue that infarcted and tissue that survived. Within the presenting apparent diffusion coefficient lesion, intracellular pH differed between tissue with early apparent diffusion lesion pseudonormalization and tissue with true radiographic recovery. These findings support the need for further investigation of pH-weighted imaging in patients with acute ischaemic stroke.
Content may be subject to copyright.
REPORT
Identifying the ischaemic penumbra using
pH-weighted magnetic resonance imaging
George W. J. Harston,
1
Yee Kai Tee,
2,3
Nicholas Blockley,
4
Thomas W. Okell,
4
Sivarajan Thandeswaran,
1
Gabriel Shaya,
1
Fintan Sheerin,
5
Martino Cellerini,
5
Stephen Payne,
2
Peter Jezzard,
4
Michael Chappell
2
and James Kennedy
1
The original concept of the ischaemic penumbra suggested imaging of regional cerebral blood flow and metabolism would be required
to identify tissue that may benefit from intervention. Amide proton transfer magnetic resonance imaging, a chemical exchange satur-
ation transfer technique, has been used to derive cerebral intracellular pH in preclinical stroke models and has been proposed as a
metabolic marker of ischaemic penumbra. In this proof of principle clinical study, we explored the potential of this pH-weighted
magnetic resonance imaging technique at tissue-level. Detailed voxel-wise analysis was performed on data from a prospective cohort of
12 patients with acute ischaemic stroke. Voxels within ischaemic core had a more severe intracellular acidosis than hypoperfused tissue
recruited to the final infarct (P50.0001), which in turn was more acidotic than hypoperfused tissue that survived (P50.0001). In
addition, when confined to the grey matter perfusion deficit, intracellular pH (P50.0001), but not cerebral blood flow (P= 0.31),
differed between tissue that infarcted and tissue that survived. Within the presenting apparent diffusion coefficient lesion, intracellular
pH differed between tissue with early apparent diffusion lesion pseudonormalization and tissue with true radiographic recovery. These
findings support the need for further investigation of pH-weighted imaging in patients with acute ischaemic stroke.
1 Acute Stroke Programme, Radcliffe Department of Medicine, University of Oxford, UK
2 Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, UK
3 Department of Mechatronics and Biomedical Engineering, Lee Kong Chian Faculty of Engineering and Science, Universiti Tunku
Abdul Rahman, Malaysia
4 Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, UK
5 Department of Neuroradiology, Oxford University Hospitals NHS Trust, Oxford, UK
Correspondence to: Dr James Kennedy,
Acute Vascular Imaging Centre, University of Oxford, Level 2,
John Radcliffe Hospital, Headington, Oxford, OX3 9DU, UK
E-mail: james.kennedy@rdm.ox.ac.uk
Keywords: ischaemic stroke; magnetic resonance imaging; chemical exchange saturation transfer; acidosis; pH-weighted imaging
Abbreviations: ADC = apparent diffusion coefficient; APTR* = amide proton transfer ratio; ASL = arterial spin labelling;
CBF = cerebral blood flow; PWI = perfusion weighted imaging
Introduction
The original concept of the ischaemic penumbra suggested
that concurrent imaging of regional cerebral blood flow
(CBF) and metabolism would be required to identify
tissue at risk that may benefit from intervention (Astrup
et al., 1981). Although there have been major technological
advances in acute stroke imaging since this was proposed,
the search for robust evidence to support individual ima-
ging-guided treatment decisions is ongoing (Kidwell, 2013;
Wintermark et al., 2013). A contributing factor may be
that, aside from PET imaging, the development of
doi:10.1093/brain/awu374 BRAIN 2015: 138; 36–42 |36
Received May 15, 2014. Revised September 8, 2014. Accepted October 1, 2014
ßThe Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits
non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
by guest on January 7, 2015Downloaded from
metabolic imaging markers has been limited when com-
pared to the focus on methods to assess perfusion.
Cerebral intracellular pH is maintained until CBF drops
to levels associated with irreversible infarction (Hossmann,
1994). Amide proton transfer MRI, a chemical exchange
saturation transfer imaging technique, can be used to gen-
erate a pH-weighted imaging signal through the assessment
of the base-catalyzed and, hence, pH-dependent intracellu-
lar transfer of protons between amide groups and water
(Zhou et al., 2003). It has been proposed that pH-weighted
imaging may improve the delineation of tissue at risk by
separating benign oligaemia from an acidotic ischaemic
penumbra (Zhou and van Zijl, 2011). Preclinical studies
have supported this potential as a biomarker of the ischae-
mic penumbra (Cho et al., 2007; Sun et al., 2007, 2011),
but to date the limited clinical application of pH-weighted
imaging has not systematically demonstrated its potential in
patients exclusively with acute stroke (Sun et al., 2010;
Zhao et al., 2011; Tee et al., 2014; Tietze et al., 2014).
Using detailed voxel-wise analysis to understand tissue-
level effects, this proof of principle clinical study assesses
the relationship between intracellular pH and final tissue
outcome in data from a prospective cohort of patients
with acute ischaemic stroke. In doing so, this study ex-
plores how pH-weighted imaging may be used in conjunc-
tion with the established acute stroke imaging modalities,
diffusion and perfusion weighted imaging, to define the
ischaemic penumbra.
Materials and methods
Patients
Patients presenting with ischaemic stroke within 12 h of symp-
tom onset (using the last seen well principle) regardless of age or
stroke severity were recruited into a prospective observational
cohort study following informed consent or agreement from a
representative according to protocols approved by UK National
Research Ethics Service committees (ref: 12/SC/0292 and 13/SC/
0362). Exclusion criteria included the presence of a contraindi-
cation for MRI and a diffusion weighted imaging or arterial spin
labelling perfusion weighted imaging (ASL-PWI) lesion 55mm
in axial diameter. MRI was performed at presentation, 24 h, 1
week, and 1 month. All clinical decisions, for example to throm-
bolyze the patient if indicated, were made prior to enrolment in
order not to introduce any delay to best clinical care. The re-
search scanning often took place while thrombolysis was
taking place (Table 1).
Image acquisition
A Siemens 3 T Verio scanner was used at all time points.
Scanning protocols included diffusion weighted imaging
(three directions, 1.8 1.8 2.0 mm, field of view = 240 mm,
four averages, b = 0 and 1000 s/mm
2
, repetition time =
9000 ms, echo time = 98 ms, 50 slices, 2 min 53 s) with appar-
ent diffusion coefficient (ADC) calculation; T
1
-weighted MP-
RAGE (1.8 1.8 1.0 mm, field of view = 228 mm, repetition
time = 2040 ms, echo time = 4.55 ms, inversion time = 900 ms,
3 min 58 s); vessel-encoded pseudocontinuous ASL-PWI
(3.4 3.4 4.5 mm, field of view = 220mm, repetition
time = 4080 ms, echo time = 14ms, echo planar imaging,
24 slices, 5 min 55 s) with multiple post-labelling delays (six
delays: 0.25 s, 0.5 s, 0.75 s, 1 s, 1.25 s, 1.5 s) (Okell et al.,
2013); and T
2
-weighted FLAIR turbo spin echo
(1.9 1.9 2.0 mm, field of view = 240 mm, repetition
time = 9000 ms, echo time = 96 ms, inversion time = 2500 ms).
pH-weighted images were acquired by estimating amide
proton transfer effect using single-slice chemical exchange sat-
uration transfer echo planar imaging localized to the lesion on
diffusion weighted imaging (3.0 3.0 5.0 mm, field of
view = 240 mm, repetition time = 5000 ms, echo time = 28 ms,
echo planar imaging, 1 slice, 2 min 45 s). The chemical
exchange saturation transfer preparation consisted of a 2 s
train of 50 Gaussian pulses (flip angle = 184, power =
0.55 mT, duration = 20 ms, delay time = 20 ms) over 32
Table 1 Patient characteristics
Patient Stroke
syndrome
Hemisphere Sex Age NIHSS Thrombolysed Onset to scan,
(h:min)
24 h MRI Follow-up
MRI (days)
1 LACS Left F 84 3 N 03:25 Y 1 month (37)
2 TACS Left M 92 25 Y 02:50 Y 1 week (7)
3 PACS Right M 64 3 N 01:41 Y 1 month (37)
4 POCS Left M 80 3 N 11:06 N 1 month (37)
5 TACS Left F 86 27 N 03:09 Y 1 month (25)
6 TACS Left F 81 21 N 03:25 Y 1 week (4)
7 PACS Left M 95 19 Y* 04:14 Y 1 month (47)
8 TACS Left F 53 13 Y 02:48 Y 1 month (34)
9 LACS Right M 57 7 N 01:43 Y 1 month (67)
10 TACS Right F 79 14 Y* 09:50 N 1 month (27)
11 PACS Left F 78 9 Y 02:50 Y NA
12 PACS Left F 55 7 Y 01:35 Y 1 month (31)
NIHSS = National Institute for Health Stroke Scale; LACS = lacunar stroke; TACS = total anterior circulation stroke; PACS = partial anterior circulation stroke; POCS = posterior
circulation stroke; NA = not available.
*Patients 7 and 10 received thrombolysis prior to the MRI scan rather than during it. Patient 7 finished thrombolysis immediately prior to imaging. Patient 10 was imaged 6 h after
thrombolysis.
pH-weighted MRI in acute stroke BRAIN 2015: 138; 36–42 |37
by guest on January 7, 2015Downloaded from
frequency offsets with an optimized sampling schedule from
4.5 to 4.5 ppm (Tee et al., 2013, 2014).
Postprocessing
All image analysis was performed using FSL (Jenkinson et al.,
2012) and MATLAB (The Mathworks Inc.). Following
brain extraction and automated tissue segmentation of the
T
1
-weighted image to define grey matter, white matter and
CSF, registration within participants used a six degrees-of-free-
dom rigid body linear transformation to the T
1
-weighted
image (Zhang et al., 2001; Jenkinson et al., 2002; Smith,
2002). ASL-PWI was processed using a non-linear fit to the
general arterial spin labelling (ASL) kinetic model for all voxels
within a brain mask to quantify CBF (Chappell et al., 2010;
Okell et al., 2013). Perfusion maps were registered to the
T
1
-weighted image as above. pH-weighted imaging was
retrospectively motion corrected using the MCFLIRT tool,
registered to the first slice acquired (Jenkinson et al., 2002).
pH-weighted signal was quantified using amide proton transfer
ratio (APTR*) (Chappell et al., 2013; Tee et al., 2014) where
low values represent intracellular acidosis. pH-weighted images
were then co-registered with the corresponding T
1
-weighted
image slice, to which it was aligned at the time of acquisition,
using the 2D registration schedule within FSL (Jenkinson et al.,
2012) and checked for accuracy by a clinician.
Amide proton transfer ratio analysis
APTR* is a metric combining the effect of amide-proton
exchange rate, which is directly related to pH, and relative
concentration of amide-bearing molecules. APTR* does not
rely upon data from saturation frequencies on the opposite
site of the water resonance as a reference unlike conventional
APTR, avoiding changes that might occur in ischaemia unre-
lated to pH, such as B
0
inhomogeneity (Chappell et al., 2013).
APTR* has been found to be more homogenous than APTR in
healthy subjects and acute stroke patients producing better
contrast-to-noise ratio between ischaemic and normal tissue
(Tee et al., 2014).
APTR* is derived from model-based analysis of the amide
proton transfer z-spectrum and controls for the effects of B
0
inhomogeneity, T
1
and T
2
. APTR* is calculated using the
fitted model parameters from a three-pool exchange model;
APTR* = [S
w
(3.5 ppm) S
w+a
(3.5 ppm)] / M
w0
, where S refers
to the simulated signal at 3.5 ppm using the fitted model par-
ameters, subscripts w and w + a refer to water pool and both
water and amide pools, and M
w0
is the fitted unsaturated
signal. The three-pool exchange model used for the data fit-
ting was water, amide and asymmetry magnetization transfer.
The third pool represents a combination of the saturation
effect observed at the negative frequency offsets and the con-
ventional magnetization transfer (Hua et al., 2007; Chappell
et al., 2013).
Regions of interest
Binary masks of presenting and 24-h ADC lesions (ADC
0
and ADC
24
) were automatically generated using a threshold-
defined (620 10
6
mm
2
/s) (Purushotham et al., 2013) clus-
ter-based analysis of the ADC data. Presenting perfusion def-
icits were defined using a threshold of 20 ml/100 g/min to
guide delineation of the region (Bristow et al., 2005). Both
ADC and perfusion region of interest clusters were identified
and smoothed [Gaussian kernel of standard deviation 1 mm
(ADC) and 2 mm (perfusion)], followed by repeat cluster ana-
lysis (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/Cluster). The auto-
mated ADC and perfusion masks were inspected to ensure
their accuracy and manually corrected when necessary. Final
infarct was preferentially defined manually on the 1-month
FLAIR image, or, if not available, on the 1-week image.
Non-linear registration was used to register the 1-week
images to the presenting T
1
-weighted image to minimize any
overestimation of final FLAIR infarct due to any oedema
still present at this time (Jenkinson et al., 2012; Rekik et al.,
2012). A representative contralateral region of interest was
defined manually on the FLAIR image and blind to the pro-
cessed APTR* data.
The following tissue outcome definitions were used in the
analysis: (i) ischaemic core: tissue present in both ADC
0
and
final FLAIR infarct; (ii) infarct growth: tissue present in the
final FLAIR infarct but not in the ADC
0
; (iii) oligaemia: tissue
present in the perfusion deficit but not the final FLAIR infarct;
(iv) diffusion lesion pseudonormalization: tissue present in
the ADC
0
but not ADC
24
; that is present in the final FLAIR
infarct; and (v) radiographic recovery: tissue present in the
ADC
24
but not the final FLAIR infarct (Supplementary Fig. 1).
Data extraction and analysis
Voxel-wise analysis was used to calculate mean presenting
APTR* for each region of interest mask transformed to
native amide proton transfer image space within a tissue
mask. To enable the secondary analysis of comparing present-
ing APTR*, grey matter perfusion and ADC directly, APTR*,
CBF and ADC were co-registered to T
1
-weighted image space.
Data were extracted from the regions of interest within a grey
matter mask. APTR*, CBF and ADC were calculated relative
to the contralateral region of interest enabling composite
voxel-wise analysis across patients. Statistical tests used were
unpaired t-tests for direct comparison between the means in
the regions of interest and using ANOVA for multiple region
of interest comparisons.
Results
Of 18 eligible patients recruited, 12 were included in the
analysis (Table 1). Three patients were excluded because of
motion corruption, two because of artefact in the APTR*
images (ringing and partial volume effects) and one de-
veloped secondary haemorrhage during the initial MRI.
The median symptom onset to MRI was 2 h 59 min
(range 1 h 35 min to 11 h 6 min) and the median National
Institute for Health Stroke Scale at presentation was 11
(minimum: 3, maximum: 27). Six patients received intra-
venous thrombolysis. Images from representative patients
are presented in Fig. 1.
Tissue in ischaemic core, infarct growth and oligaemia
regions of interest all demonstrated a reduced APTR* rela-
tive to the contralateral hemisphere [mean standard de-
viation (number of voxels); ischaemic core: 0.86 0.11
(636); infarct growth: 0.92 0.11 (912); oligaemia:
38 |BRAIN 2015: 138; 36–42 G. W. J. Harston et al.
by guest on January 7, 2015Downloaded from
Figure 1 Images from representative patients. Regions of interest: green = oligaemia; blue = infarct growth; red = ischaemic core.
NA = not available. Scale for ASL-PWI = cerebral blood flow, ml/100g/min. Scale for pH-weighted imaging = APTR*, no units.
pH-weighted MRI in acute stroke BRAIN 2015: 138; 36–42 |39
by guest on January 7, 2015Downloaded from
0.97 0.11 (592)] (Fig. 2 and Supplementary Table 1).
Relative APTR* within the ischaemic core was significantly
lower than within the infarct growth voxels (P50.0001,
unpaired t-test), which in turn had lower relative APTR*
than oligaemia regions (P50.0001, unpaired t-test).
Data from individual patients in Fig. 1 can be seen in
Supplementary Fig. 2.
Those voxels within the ADC lesions that demonstrated
diffusion lesion pseudonormalization [0.82 0.12 (47)
had significantly lower relative APTR* than the ischaemic
core (0.86 0.11 (636), P= 0.03, unpaired t-test] (Fig. 2).
In contrast, those regions undergoing radiographic recovery
had an APTR* greater than the contralateral hemisphere
[1.06 0.13 (129)] (Fig. 2). Within the ADC lesions, there
was a gradation of mean ADC by final tissue outcome
(Supplementary Fig. 3).
Within the grey matter, CBF did not distinguish between
regions of ischaemic core, infarct growth or oligaemia
(P= 0.31, ANOVA) although there was more variation in
CBF within the ischaemic core than infarct growth regions
(variance ratio = 2.5, P50.01) (Fig. 3 and Supplementary
Fig. 4). In contrast, there was a significant difference in rela-
tive APTR* between regions of infarct growth and oli-
gaemia within the grey matter (P50.0001, unpaired
t-test), and although the relative APTR* within the ischae-
mic core was lower than the regions of infarct growth, this
was not significant (P= 0.52). With the perfusion deficit,
the relative ADC value was reduced only in the ischaemic
core (Supplementary Fig. 4).
Figure 2 Mean relative APTR* of region of interest voxels
within the perfusion deficit (top) and within the ADC lesion
(bottom). Analysis in pH-weighted image space within a tissue
mask; error bars represent 95% confidence intervals.
****P50.0001; *P50.05.
Figure 3 Mean relative CBF (top) and relative APTR*
(bottom) for region of interest voxels within the perfusion
deficit, restricted to grey matter voxels only. Analysis in T
1
-
weighted image space within a grey matter mask; error bars rep-
resent 95% confidence intervals. ****P50.0001.
40 |BRAIN 2015: 138; 36–42 G. W. J. Harston et al.
by guest on January 7, 2015Downloaded from
Discussion
Using detailed group-level voxel-wise analysis we demon-
strate the potential clinical use of pH-weighted MRI in
acute ischaemic stroke. This study builds on previous
work to optimize the generation of a pH-weighted signal
to show that intracellular pH at presentation is significantly
associated with final tissue outcome, providing complemen-
tary information to existing ASL-PWI and diffusion
weighted imaging sequences in the clinical setting of acute
stroke (Sun et al., 2010; Zhao et al., 2011; Tee et al., 2014;
Tietze et al., 2014). It entails the use of a sequence acqui-
sition that is clinically pragmatic (it is 3 min in duration),
and does not require contrast (e.g. gadolinium) or exogen-
ous stimulus (e.g. inhaled gas such as carbogen) to derive a
signal that is present in both grey and white matter
(Tee et al., 2014).
This study shows a biologically plausible signal of intra-
cellular acidosis associated with final tissue outcome.
Intracellular acidosis develops in part as a consequence of
unopposed anaerobic ATP hydrolysis, with hypoperfusion
and reduced bicarbonate buffering at acidic pH exacerbat-
ing the acidosis (Sun et al., 2011). Within a perfusion-
defined lesion, the ischaemic core is more acidotic than
tissue that is subsequently recruited to the final infarct.
Tissue within the region of interest of oligaemia that ultim-
ately does not infarct is significantly less acidotic than
either ischaemic core or infarct growth.
The inherently low signal-to-noise ratio when using ASL
to measure CBF in white matter (van Gelderen et al., 2008;
Alsop et al., 2014), alongside the sensitivity of ASL to
delays in arterial arrival time, provide challenges in the
accurate determination of the perfusion deficit and may
affect reliable determination of CBF. This was overcome,
in part, by the use of multiple post-labelling delays (Okell
et al., 2013). Furthermore, when comparing pH-weighted
imaging to ASL-PWI within the regions of interest repre-
senting different tissue outcomes, analysis was confined to
grey matter to minimize any insensitivity introduced by
ASL-PWI. Within threshold-defined ischaemic grey matter,
pH-weighted imaging, but not ASL-PWI, differed between
tissues with different outcomes. Outside of the ischaemic
core, relative ADC values were not helpful in discriminat-
ing final tissue outcome. This supports the hypothesis that
pH-weighted imaging separates the diffusion-perfusion mis-
match into zones of acidotic ischaemic penumbra (low CBF
with evidence of metabolic stress) and benign oligaemia
(low CBF with minimal evidence of metabolic stress) in a
way consistent with the preclinical data (Sun et al., 2007;
Zhou and van Zijl, 2011).
pH-weighted MRI provides an insight into ADC lesion
reversal, which has variously been reported at 6.7% to
50% of the presenting ADC lesion (Inoue et al., 2014).
This study corroborates the PET imaging finding that
there is heterogeneity of metabolism within the ADC
lesion and that this seems to be linked to ADC reversal
(Guadagno et al., 2006). Tissue within regions of diffusion
lesion pseudonormalization is more severely acidotic at
presentation than the ischaemic core, consistent with
more aggressive tissue injury with vasogenic oedema and
early pseudonormalization of ADC by 24 h (Inoue et al.,
2014). In contrast, tissue with radiographic recovery has an
intracellular alkalosis. This is again a biologically plausible
signature of tissue maintaining ATP levels, and hence via-
bility, through the transfer of phosphate from phosphocrea-
tine to ADP (adenosine diphosphate) with resultant
intracellular alkalosis (Erecinska and Silver, 1989).
Further technical development, such as 3D image acqui-
sition to overcome challenges pertaining to single-slice data
(including registration errors), rapid image analysis and
improving signal-to-noise ratio, is required before pH-
weighted imaging becomes a widely clinically relevant
imaging modality influencing treatment decisions for indi-
viduals. In keeping with other acute stroke MRI modalities,
further work is required to limit issues related to motion
corruption and partial volume effects. Addressing these
will enable larger studies to assess the interaction of the
pH-weighted signal with physiological (e.g. glucose, tem-
perature), treatment, and imaging (e.g. perfusion dynamics)
parameters.
In conclusion, pH-weighted imaging may have a role in
improving the imaging definition of ischaemic penumbra,
and may also be useful in a better understanding of re-
gional vulnerability and secondary injury, addressing an
unmet need of MRI biomarkers in acute stroke (Kidwell,
2013). In addition, given pH is a physiological parameter
that can be manipulated, pH-weighted imaging has the
potential to meet the criteria of a treatment-relevant
acute imaging target (Wintermark et al., 2013). This
proof of principle study at a tissue level of analysis
strongly supports the further investigation of pH-weighted
imaging in patients with acute ischaemic stroke when
used in combination with diffusion and perfusion weighted
imaging.
Acknowledgements
We wish to acknowledge the facilities provided by the
Oxford Acute Vascular Imaging Centre and the staff of
the Oxford Acute Stroke Programme.
Funding
This study was supported by the National Institute for
Health Research Oxford Biomedical Research Centre
Programme, the National Institute for Health Research
Clinical Research Network, the Dunhill Medical Trust
[grant number: OSRP1/1006] and the Centre of
Excellence for Personalized Healthcare funded by the
Wellcome Trust and Engineering and Physical Sciences
Research Council [grant number WT088877/Z/09/Z].
pH-weighted MRI in acute stroke BRAIN 2015: 138; 36–42 |41
by guest on January 7, 2015Downloaded from
Supplementary material
Supplementary material is available at Brain online.
Conflict of interest
Professor Chappell, Professor Jezzard and Dr Okell have
received royalties from Siemens Healthcare through licen-
sing of US patents. Professor Chappell has received royal-
ties for commercial licenses from the FMRIB software
library.
References
Alsop DC, Detre JA, Golay X, Gunther M, Hendrikse J, Hernandez-
Garcia L, et al. Recommended implementation of arterial spin-
labeled perfusion MRI for clinical applications: a consensus of the
ISMRM perfusion study group and the European consortium for
ASL in dementia. Magn Reson Med. Advance Access published on
April 8, 2014, doi: 10.1002/mrm.25197.
Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia - the
ischemic penumbra. Stroke 1981; 12: 723–5.
Bristow MS, Simon JE, Brown RA, Eliasziw M, Hill MD, Coutts SB,
et al. MR perfusion and diffusion in acute ischemic stroke: human
gray and white matter have different thresholds for infarction.
J Cereb Blood Flow Metab 2005; 25: 1280–7.
Chappell MA, Donahue MJ, Tee YK, Khrapitchev AA, Sibson NR,
Jezzard P, et al. Quantitative bayesian model-based analysis of
amide proton transfer MRI. Magn Reson Med 2013; 70: 556–67.
Chappell MA, Okell TW, Jezzard P, Woolrich MW. A general frame-
work for the analysis of vessel encoded arterial spin labeling for
vascular territory mapping. Magn Reson Med 2010; 64: 1529–39.
Cho SH, Kim DG, Kim DS, Kim YH, Lee CH, Jang SH. Motor out-
come according to the integrity of the corticospinal tract determined
by diffusion tensor tractography in the early stage of corona radiata
infarct. Neurosci Lett 2007; 426: 123–7.
Erecinska M, Silver IA. ATP and brain function. J Cereb Blood Flow
Metab 1989; 9: 2–19.
Guadagno JV, Warburton EA, Jones PS, Day DJ, Aigbirhio FI,
Fryer TD, et al. How affected is oxygen metabolism in DWI
lesions?: a combined acute stroke PET-MR study. Neurology
2006; 67: 824–9.
Hossmann KA. Viability thresholds and the penumbra of focal ische-
mia. Ann Neurol 1994; 36: 557–65.
Hua J, Jones CK, Blakeley J, Smith SA, van Zijl PC, Zhou J.
Quantitative description of the asymmetry in magnetization transfer
effects around the water resonance in the human brain. Magn Reson
Med 2007; 58: 786–93.
Inoue M, Mlynash M, Christensen S, Wheeler HM, Straka M,
Tipirneni A, et al. Early diffusion-weighted imaging reversal after
endovascular reperfusion is typically transient in patients imaged 3
to 6 hours after onset. Stroke 2014; 45: 1024–8.
Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization
for the robust and accurate linear registration and motion correction
of brain images. Neuroimage 2002; 17: 825–41.
Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM.
FSL. Neuroimage 2012; 62: 782–90.
Kidwell CS. MRI biomarkers in acute ischemic stroke: a conceptual
framework and historical analysis. Stroke 2013; 44: 570–8.
Okell TW, Chappell MA, Kelly ME, Jezzard P. Cerebral blood flow
quantification using vessel-encoded arterial spin labeling. J Cereb
Blood Flow Metab 2013; 33: 1716–24.
Purushotham A, Campbell BC, Straka M, Mlynash M, Olivot JM,
Bammer R, et al. Apparent diffusion coefficient threshold for delin-
eation of ischemic core. Int J Stroke. Advance Access published on
June 27, 2013, doi: 10.1111/ijs.12068.
Rekik I, Allassonniere S, Carpenter TK, Wardlaw JM. Medical image
analysis methods in MR/CT-imaged acute-subacute ischemic stroke
lesion: segmentation, prediction and insights into dynamic evolution
simulation models. A critical appraisal. NeuroImage Clin 2012; 1:
164–78.
Smith SM. Fast robust automated brain extraction. Human Brain
Mapp 2002; 17: 143–55.
Sun PZ, Benner T, Copen WA, Sorensen AG. Early experience of
translating pH-weighted MRI to image human subjects at 3 tesla.
Stroke 2010; 41: S147–51.
Sun PZ, Cheung JS, Wang E, Lo EH. Association between pH-
weighted endogenous amide proton chemical exchange saturation
transfer MRI and tissue lactic acidosis during acute ischemic
stroke. J Cereb Blood Flow Metab 2011; 31: 1743–50.
Sun PZ, Zhou J, Sun W, Huang J, van Zijl PC. Detection of the
ischemic penumbra using pH-weighted MRI. J Cereb Blood Flow
Metab 2007; 27: 1129–36.
Tee YK, Harston GW, Blockley N, Okell TW, Levman J, Sheerin F,
et al. Comparing different analysis methods for quantifying the MRI
amide proton transfer (APT) effect in hyperacute stroke patients.
NMR Biomed 2014; 27: 1019–29.
Tee YK, Khrapitchev AA, Sibson NR, Payne SJ, Chappell MA.
Optimal sampling schedule for chemical exchange saturation trans-
fer. Magn Reson Med 2013; 70: 1251–62.
Tietze A, Blicher J, Mikkelsen IK, Ostergaard L, Strother MK,
Smith SA, et al. Assessment of ischemic penumbra in patients with
hyperacute stroke using amide proton transfer (APT) chemical
exchange saturation transfer (CEST) MRI. NMR Biomed 2014;
27: 163–74.
van Gelderen P, de Zwart JA, Duyn JH. Pittfalls of MRI measurement
of white matter perfusion based on arterial spin labeling. Magn
Reson Med 2008; 59: 788–95.
Wintermark M, Albers GW, Broderick JP, Demchuk AM, Fiebach JB,
Fiehler J, et al. Acute stroke imaging research roadmap II. Stroke
2013; 44: 2628–39.
Zhang Y, Brady M, Smith S. Segmentation of brain MR images
through a hidden Markov random field model and the expect-
ation-maximization algorithm. IEEE Trans Med Imaging 2001; 20:
45–57.
Zhao X, Wen Z, Huang F, Lu S, Wang X, Hu S, et al. Saturation
power dependence of amide proton transfer image contrasts in
human brain tumors and strokes at 3 T. Magn Reson Med 2011;
66: 1033–41.
Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC. Using the
amide proton signals of intracellular proteins and peptides to detect
pH effects in MRI. Nat Med 2003; 9: 1085–90.
Zhou J, van Zijl PC. Defining an acidosis-based ischemic penumbra
from pH-weighted MRI. Transl Stroke Res 2011; 3: 76–83.
42 |BRAIN 2015: 138; 36–42 G. W. J. Harston et al.
by guest on January 7, 2015Downloaded from
... 44 Another study involving acute stroke patients revealed only a marginal relative APT signal decrease: approximately 86% in the core, 92% in the IGR, and 97% in the oligemia. 46 In previous studies, the infarct growth region was usually defined as the difference between the early infarct from the ADC core and the final infarct obtained by T 2 -weighted imaging, 46 typically at 24 h after the occlusion. Because the ADC lesion in the rat MCAO model approaches a steady state at about 3-4 h following occlusion that is very close to the 24 T 2 -defined infarcts, [47][48][49] we used ADC lesion progression from 1 to 5 h as a surrogate for IGR in this study. ...
... 44 Another study involving acute stroke patients revealed only a marginal relative APT signal decrease: approximately 86% in the core, 92% in the IGR, and 97% in the oligemia. 46 In previous studies, the infarct growth region was usually defined as the difference between the early infarct from the ADC core and the final infarct obtained by T 2 -weighted imaging, 46 typically at 24 h after the occlusion. Because the ADC lesion in the rat MCAO model approaches a steady state at about 3-4 h following occlusion that is very close to the 24 T 2 -defined infarcts, [47][48][49] we used ADC lesion progression from 1 to 5 h as a surrogate for IGR in this study. ...
Article
Full-text available
Purpose Differentiating ischemic brain damage is critical for decision making in acute stroke treatment for better outcomes. We examined the sensitivity of amide proton transfer (APT) MRI, a pH‐weighted imaging technique, to achieve this differentiation. Methods In a rat stroke model, the ischemic core, oligemia, and the infarct‐growth region (IGR) were identified by tracking the progression of the lesions. APT MRI signals were measured alongside ADC, T1, and T2 maps to evaluate their sensitivity in distinguishing ischemic tissues. Additionally, stroke under hyperglycemic conditions was studied. Results The APT signal in the IGR decreased by about 10% shortly after stroke onset, and further decreased to 35% at 5 h, indicating a progression from mild to severe acidosis as the lesion evolved into infarction. Although ADC, T1, and T2 contrasts can only detect significant differences between the IGR and oligemia for a portion of the stroke duration, APT contrast consistently differentiates between them at all time points. However, the contrast to variation ratio at 1 h is only about 20% of the contrast to variation ratio between the core and normal tissues, indicating limited sensitivity. In the ischemic core, the APT signal decreases to about 45% and 33% of normal tissue level at 1 h for the normoglycemic and hyperglycemic groups, respectively, confirming more severe acidosis under hyperglycemia. Conclusion The sensitivity of APT MRI is high in detecting severe acidosis of the ischemic core but is much lower in detecting mild acidosis, which may affect the accuracy of differentiation between the IGR and oligemia.
... Amide proton transfer (APT) imaging, a type of CEST-MRI, is a potentially important molecular MRI method that can generate contrast based on the concentration of endogenous mobile proteins and peptides [2,3]. APT imaging has been reported to be valuable for identifying the penumbral region in patients with cerebral infarction, for diagnosing neurological disorders such as multiple sclerosis, for assessing lymphedema in the upper extremities, and for differentiating brain tumors [4,5]. ...
Article
Full-text available
Purpose The preoperative assessment of carotid plaques is necessary to render revascularization safe and effective. The aim of this study is to evaluate the usefulness of chemical exchange saturation transfer (CEST)-MRI, particularly amide proton transfer (APT) imaging as a preoperative carotid plaque diagnostic tool. Methods We recorded the APT signal intensity on concentration maps of 34 patients scheduled for carotid endarterectomy. Plaques were categorized into group A (APT signal intensity ≥ 1.90 E-04; n = 12) and group B (APT signal intensity < 1.90 E-04; n = 22). Excised plaques were subjected to histopathological assessment and, using the classification promulgated by the American Heart Association, they were classified as intraplaque hemorrhage-positive [type VI-positive (tVI⁺)] and -negative [no intraplaque hemorrhage (tVI⁻)]. Results Of the 34 patients, 22 (64.7%) harbored tVI⁺- and 12 (35.3%) had tVI⁻ plaques. The median APT signals were significantly higher in tVI⁺- than tIVI⁻ patients (2.43 E-04 (IQR = 0.98–4.00 E-04) vs 0.54 E-04 (IQR = 0.14–1.09 E-04), p < .001). Histopathologically, the number of patients with tVI⁺ plaques was significantly greater in group A (100%, n = 12) than group B (45%, n = 22) (p < .01). The number of symptomatic patients or asymptomatic patients with worsening stenosis was also significantly greater in group A than group B (75% vs 36%, p < .01). Conclusion In unstable plaques with intraplaque hemorrhage and in patients with symptoms or progressive stenosis, the ATP signals were significantly elevated. CEST-MRI studies has the potential for the preoperative assessment of the plaques’ characteristics.
... are two major effects that have been widely studied. They have demonstrated potentials in various applications, including tumor detection (20)(21)(22)(23), ischemic stroke identification (24)(25)(26), and the diagnosis of multiple neurological disorders (27)(28)(29)(30)(31)(32)(33)(34)(35). ...
Preprint
Full-text available
Purpose To develop a SNR enhancement method for chemical exchange saturation transfer (CEST) imaging using a denoising convolutional autoencoder (DCAE), and compare its performance with state-of-the-art denoising methods. Method The DCAE-CEST model encompasses an encoder and a decoder network. The encoder learns features from the input CEST Z-spectrum via a series of 1D convolutions, nonlinearity applications and pooling. Subsequently, the decoder reconstructs an output denoised Z-spectrum using a series of up-sampling and convolution layers. The DCAE-CEST model underwent multistage training in an environment constrained by Kullback–Leibler divergence, while ensuring data adaptability through context learning using Principal Component Analysis processed Z-spectrum as a reference. The model was trained using simulated Z-spectra, and its performance was evaluated using both simulated data and in-vivo data from an animal tumor model. Maps of amide proton transfer (APT) and nuclear Overhauser enhancement (NOE) effects were quantified using the multiple-pool Lorentzian fit, along with an apparent exchange-dependent relaxation metric. Results In digital phantom experiments, the DCAE-CEST method exhibited superior performance, surpassing existing denoising techniques, as indicated by the peak SNR and Structural Similarity Index. Additionally, in vivo data further confirms the effectiveness of the DCAE-CEST in denoising the APT and NOE maps when compared to other methods. While no significant difference was observed in APT between tumors and normal tissues, there was a significant difference in NOE, consistent with previous findings. Conclusion The DCAE-CEST can learn the most important features of the CEST Z-spectrum and provide the most effective denoising solution compared to other methods.
... Recent studies suggest that pH can serve as a metabolic marker for distinguishing the ischemic core and penumbra following an IS. Nanotechnology offers promising prospects for utilizing pH-responsive NPs in delivering drugs to ischemic brain tissue (Harston et al., 2015;Leigh et al., 2018;Cheung et al., 2021). pH-responsive properties are typically attained through the utilization of chemical bonds that are stable at physiological pH value while susceptible to breakage at low pH values. ...
Article
Full-text available
Ischemic stroke (IS) refers to local brain tissue necrosis which is caused by impaired blood supply to the carotid artery or vertebrobasilar artery system. As the second leading cause of death in the world, IS has a high incidence and brings a heavy economic burden to all countries and regions because of its high disability rate. In order to effectively treat IS, a large number of drugs have been designed and developed. However, most drugs with good therapeutic effects confirmed in preclinical experiments have not been successfully applied to clinical treatment due to the low accumulation efficiency of drugs in IS areas after systematic administration. As an emerging strategy for the treatment of IS, stimuli-responsive nanomedicines have made great progress by precisely delivering drugs to the local site of IS. By response to the specific signals, stimuli-responsive nanomedicines change their particle size, shape, surface charge or structural integrity, which enables the enhanced drug delivery and controlled drug release within the IS tissue. This breakthrough approach not only enhances therapeutic efficiency but also mitigates the side effects commonly associated with thrombolytic and neuroprotective drugs. This review aims to comprehensively summarize the recent progress of stimuli-responsive nanomedicines for the treatment of IS. Furthermore, prospect is provided to look forward for the better development of this field.
... 10 For example, exchange rates of protons are reduced in acid environments, such as ischemic stroke, which results in lower APTw values. 33 Higher APTw values in tumors can be explained by two elements: (1) higher concentrations of cytosolic proteins and peptides caused by increased cell density, and (2) a slightly higher intracellular pH increasing the exchange rates of the protons. 34 Furthermore, elevated levels of mobile proteins are not specific for solid tumor tissue since tumor cysts can contain high protein concentration as well. ...
Article
Amide proton transfer weighted (APTw) imaging enables in vivo assessment of tissue‐bound mobile proteins and peptides through the detection of chemical exchange saturation transfer. Promising applications of APTw imaging have been shown in adult brain tumors. As pediatric brain tumors differ from their adult counterparts, we investigate the radiological appearance of pediatric brain tumors on APTw imaging. APTw imaging was conducted at 3 T. APTw maps were calculated using magnetization transfer ratio asymmetry at 3.5 ppm. First, the repeatability of APTw imaging was assessed in a phantom and in five healthy volunteers by calculating the within‐subject coefficient of variation (wCV). APTw images of pediatric brain tumor patients were analyzed retrospectively. APTw levels were compared between solid tumor tissue and normal‐appearing white matter (NAWM) and between pediatric high‐grade glioma (pHGG) and pediatric low‐grade glioma (pLGG) using t ‐tests. APTw maps were repeatable in supratentorial and infratentorial brain regions (wCV ranged from 11% to 39%), except those from the pontine region (wCV between 39% and 50%). APTw images of 23 children with brain tumor were analyzed (mean age 12 years ± 5, 12 male). Significantly higher APTw values are present in tumor compared with NAWM for both pHGG and pLGG ( p < 0.05). APTw values were higher in pLGG subtype pilocytic astrocytoma compared with other pLGG subtypes ( p < 0.05). Non‐invasive characterization of pediatric brain tumor biology with APTw imaging could aid the radiologist in clinical decision‐making.
Article
Chemical exchange saturation transfer (CEST) MRI is a molecular imaging tool that provides physiological information about tissues, making it an invaluable tool for disease diagnosis and guided treatment. Its clinical application requires the acquisition of high‐resolution images capable of accurately identifying subtle regional changes in vivo, while simultaneously maintaining a high level of spectral resolution. However, the acquisition of such high‐resolution images is time consuming, presenting a challenge for practical implementation in clinical settings. Among several techniques that have been explored to reduce the acquisition time in MRI, deep‐learning‐based super‐resolution (DLSR) is a promising approach to address this problem due to its adaptability to any acquisition sequence and hardware. However, its translation to CEST MRI has been hindered by the lack of the large CEST datasets required for network development. Thus, we aim to develop a DLSR method, named DLSR‐CEST, to reduce the acquisition time for CEST MRI by reconstructing high‐resolution images from fast low‐resolution acquisitions. This is achieved by first pretraining the DLSR‐CEST on human brain T1w and T2w images to initialize the weights of the network and then training the network on very small human and mouse brain CEST dataset s to fine‐tune the weights. Using the trained DLSR‐CEST network, the reconstructed CEST source images exhibited improved spatial resolution in both peak signal‐to‐noise ratio and structural similarity index measure metrics at all downsampling factors (2–8). Moreover, amide CEST and relayed nuclear Overhauser effect maps extrapolated from the DLSR‐CEST source images exhibited high spatial resolution and low normalized root mean square error, indicating a negligible loss in Z ‐spectrum information. Therefore, our DLSR‐CEST demonstrated a robust reconstruction of high‐resolution CEST source images from fast low‐resolution acquisitions, thereby improving the spatial resolution and preserving most Z ‐spectrum information.
Article
Spinal cord ischemia and hypoxia can be caused by compression, injury, and vascular alterations. Measuring ischemia and hypoxia directly in the spinal cord noninvasively remains challenging. Ischemia and hypoxia alter tissue pH, providing a physiologic parameter that may be more directly related to tissue viability. Chemical exchange saturation transfer (CEST) is an MRI contrast mechanism that can be made sensitive to pH. More specifically, amine/amide concentration independent detection (AACID) is a recently developed endogenous CEST contrast that has demonstrated sensitivity to intracellular pH at 9.4 T. The goal of this study was to evaluate the reproducibility of AACID CEST measurements at different levels of the healthy cervical spinal cord at 3.0 T incorporating B 1 correction. Using a 3.0 T MRI scanner, two 3D CEST scans (saturation pulse train followed by a 3D snapshot gradient‐echo readout) were performed on 12 healthy subjects approximately 10 days apart, with the CEST volume centered at the C4 level for all subjects. Scan–rescan reproducibility was evaluated by examining between and within‐subject coefficients of variation (CVs) and absolute AACID value differences. The C4 level of the spinal cord demonstrated the lowest within‐subject CVs (4.1%–4.3%), between‐subject CVs (5.6%–6.3%), and absolute AACID percent difference (5.8–6.1%). The B 1 correction scheme significantly improved reproducibility (adjusted p ‐value = 0.002) compared with the noncorrected data, suggesting that implementing B 1 corrections in the spinal cord is beneficial. It was concluded that pH‐weighted AACID measurements, incorporating B 1 ‐inhomogeneity correction, were reproducible within subjects along the healthy cervical spinal cord and that optimal image quality was achieved at the center of the 3D CEST volume.
Article
Full-text available
Purpose Machine learning (ML) has been increasingly used to quantify CEST effect. ML models are typically trained using either measured data or fully simulated data. However, training with measured data often lacks sufficient training data, whereas training with fully simulated data may introduce bias because of limited simulations pools. This study introduces a new platform that combines simulated and measured components to generate partially synthetic CEST data, and to evaluate its feasibility for training ML models to predict amide proton transfer (APT) effect. Methods Partially synthetic CEST signals were created using an inverse summation of APT effects from simulations and the other components from measurements. Training data were generated by varying APT simulation parameters and applying scaling factors to adjust the measured components, achieving a balance between simulation flexibility and fidelity. First, tissue‐mimicking CEST signals along with ground truth information were created using multiple‐pool model simulations to validate this method. Second, an ML model was trained individually on partially synthetic data, in vivo data, and fully simulated data, to predict APT effect in rat brains bearing 9 L tumors. Results Experiments on tissue‐mimicking data suggest that the ML method using the partially synthetic data is accurate in predicting APT. In vivo experiments suggest that our method provides more accurate and robust prediction than the training using in vivo data and fully synthetic data. Conclusion Partially synthetic CEST data can address the challenges in conventional ML methods.
Article
Full-text available
Amide proton transfer (APT) imaging is a pH mapping method based on the chemical exchange saturation transfer phenomenon that has potential for penumbra identification following stroke. The majority of the literature thus far has focused on generating pH-weighted contrast using magnetization transfer ratio asymmetry analysis instead of quantitative pH mapping. In this study, the widely used asymmetry analysis and a model-based analysis were both assessed on APT data collected from healthy subjects (n = 2) and hyperacute stroke patients (n = 6, median imaging time after onset = 2 hours 59 minutes). It was found that the model-based approach was able to quantify the APT effect with the lowest variation in grey and white matter (≤ 13.8 %) and the smallest average contrast between these two tissue types (3.48 %) in the healthy volunteers. The model-based approach also performed quantitatively better than the other measures in the hyperacute stroke patient APT data, where the quantified APT effect in the infarct core was consistently lower than in the contralateral normal appearing tissue for all the patients recruited, with the group average of the quantified APT effect being 1.5 ± 0.3 % (infarct core) and 1.9 ± 0.4 % (contralateral). Based on the fitted parameters from the model-based analysis and a previously published pH and amide proton exchange rate relationship, quantitative pH maps for hyperacute stroke patients were generated, for the first time, using APT imaging. © 2014 The Authors. NMR in Biomedicine published by John Wiley & Sons, Ltd.
Article
Full-text available
Over the last 15 years, basic thresholding techniques in combination with standard statistical correlation-based data analysis tools have been widely used to investigate different aspects of evolution of acute or subacute to late stage ischemic stroke in both human and animal data. Yet, a wave of biology-dependent and imaging-dependent issues is still untackled pointing towards the key question: “how does an ischemic stroke evolve?” Paving the way for potential answers to this question, both magnetic resonance (MRI) and CT (computed tomography) images have been used to visualize the lesion extent, either with or without spatial distinction between dead and salvageable tissue. Combining diffusion and perfusion imaging modalities may provide the possibility of predicting further tissue recovery or eventual necrosis. Going beyond these basic thresholding techniques, in this critical appraisal, we explore different semi-automatic or fully automatic 2D/3D medical image analysis methods and mathematical models applied to human, animal (rats/rodents) and/or synthetic ischemic stroke to tackle one of the following three problems: (1) segmentation of infarcted and/or salvageable (also called penumbral) tissue, (2) prediction of final ischemic tissue fate (death or recovery) and (3) dynamic simulation of the lesion core and/or penumbra evolution. To highlight the key features in the reviewed segmentation and prediction methods, we propose a common categorization pattern. We also emphasize some key aspects of the methods such as the imaging modalities required to build and test the presented approach, the number of patients/animals or synthetic samples, the use of external user interaction and the methods of assessment (clinical or imaging-based). Furthermore, we investigate how any key difficulties, posed by the evolution of stroke such as swelling or reperfusion, were detected (or not) by each method. In the absence of any imaging-based macroscopic dynamic model applied to ischemic stroke, we have insights into relevant microscopic dynamic models simulating the evolution of brain ischemia in the hope to further promising and challenging 4D imaging-based dynamic models. By depicting the major pitfalls and the advanced aspects of the different reviewed methods, we present an overall critique of their performances and concluded our discussion by suggesting some recommendations for future research work focusing on one or more of the three addressed problems.
Article
Full-text available
Arterial spin labeling (ASL) techniques are gaining popularity for visualizing and quantifying cerebral blood flow (CBF) in a range of patient groups. However, most ASL methods lack vessel-selective information, which is important for the assessment of collateral flow and the arterial supply to lesions. In this study, we explored the use of vessel-encoded pseudocontinuous ASL (VEPCASL) with multiple postlabeling delays to obtain individual quantitative CBF and bolus arrival time maps for each of the four main brain-feeding arteries and compared the results against those obtained with conventional pseudocontinuous ASL (PCASL) using matched scan time. Simulations showed that PCASL systematically underestimated CBF by up to 37% in voxels supplied by two arteries, whereas VEPCASL maintained CBF accuracy since each vascular component is treated separately. Experimental results in healthy volunteers showed that there is no systematic bias in the CBF estimates produced by VEPCASL and that the signal-to-noise ratio of the two techniques is comparable. Although more complex acquisition and image processing is required and the potential for motion sensitivity is increased, VEPCASL provides comparable data to PCASL but with the added benefit of vessel-selective information. This could lead to more accurate CBF estimates in patients with a significant collateral flow.Journal of Cerebral Blood Flow & Metabolism advance online publication, 7 August 2013; doi:10.1038/jcbfm.2013.129.
Article
This review provides a summary statement of recommended implementations of arterial spin labeling (ASL) for clinical applications. It is a consensus of the ISMRM Perfusion Study Group and the European ASL in Dementia consortium, both of whom met to reach this consensus in October 2012 in Amsterdam. Although ASL continues to undergo rapid technical development, we believe that current ASL methods are robust and ready to provide useful clinical information, and that a consensus statement on recommended implementations will help the clinical community to adopt a standardized approach. In this review, we describe the major considerations and trade-offs in implementing an ASL protocol and provide specific recommendations for a standard approach. Our conclusion is that as an optimal default implementation, we recommend pseudo-continuous labeling, background suppression, a segmented three-dimensional readout without vascular crushing gradients, and calculation and presentation of both label/control difference images and cerebral blood flow in absolute units using a simplified model.
Chapter
Function and metabolism of the brain are critically dependent on a sufficient oxygen supply. In man, cerebral blood flow (CBF) is about 50 ml/100 gm/min and the arteriovenous differences for oxygen (AVDO2) about 7 vol%, giving a cerebral oxygen consumption (CMRO2) of about 3.5 ml/100 gm/min. If CBF is moderately reduced as in the state of oligemia, the flow reduction will be balanced by a rise in AVDO2 so that a normal oxygen supply is maintained. A further reduction in CBF may still be balanced while AVDO2 approximates the arterial oxygen content, and at a normal metabolic rate, flow reductions down to about 20 ml/100 gm/min may be tolerated. This flow level is critical in the sense that below this level oxygen is insufficiently supplied, and since the AVDO2 is maximal, the CMR02 is given by the blood flow (ischemia) (Fig. l).Thus in the ischemic flow ranges a further reduction in flow enforces a proportional reduction in oxygen consumption. Experimentally this principle allows a determination of the critical low levels of local oxygen supply, given as local blood flow (CBF), leading to failure of fundamental brain tissue functions.
Article
The aim of this study was to assess the frequency and extent of early diffusion-weighted imaging (DWI) lesion reversal after endovascular therapy and to determine whether early reversal is sustained or transient. MRI with DWI perfusion imaging was performed before (DWI 1) and within 12 hours after (DWI 2) endovascular treatment; follow-up MRI was obtained on day 5. Both DWIs were coregistered to follow-up MRI. Early DWI reversal was defined as the volume of the DWI 1 lesion that was not superimposed on the DWI 2 lesion. Permanent reversal was the volume of the DWI 1 lesion not superimposed on the day 5 infarct volume. Associations between early DWI reversal and clinical outcomes in patients with and without reperfusion were assessed. A total of 110 patients had technically adequate DWI before endovascular therapy (performed median [interquartile range], 4.5 [2.8-6.2] hours after onset); 60 were eligible for this study. Thirty-two percent had early DWI reversal >10 mL; 17% had sustained reversal. The median volume of permanent reversal at 5 days was 3 mL (interquartile range, 1.7-7.0). Only 2 patients (3%) had a final infarct volume that was smaller than their baseline DWI lesion. Early DWI reversal was not an independent predictor of clinical outcome and was not associated with early reperfusion. Early DWI reversal occurred in about one third of patients after endovascular therapy; however, reversal was often transient and was not associated with a significant volume of tissue salvage or favorable clinical outcome.
Article
This review provides a summary statement of recommended implementations of arterial spin labeling (ASL) for clinical applications. It is a consensus of the ISMRM Perfusion Study Group and the European ASL in Dementia consortium, both of whom met to reach this consensus in October 2012 in Amsterdam. Although ASL continues to undergo rapid technical development, we believe that current ASL methods are robust and ready to provide useful clinical information, and that a consensus statement on recommended implementations will help the clinical community to adopt a standardized approach. In this review, we describe the major considerations and trade-offs in implementing an ASL protocol and provide specific recommendations for a standard approach. Our conclusion is that as an optimal default implementation, we recommend pseudo-continuous labeling, background suppression, a segmented three-dimensional readout without vascular crushing gradients, and calculation and presentation of both label/control difference images and cerebral blood flow in absolute units using a simplified model. Magn Reson Med, 2014. © 2014 Wiley Periodicals, Inc.
Article
Chemical exchange saturation transfer (CEST)-derived, pH-weighted, amide proton transfer (APT) MRI has shown promise in animal studies for the prediction of infarction risk in ischemic tissue. Here, APT MRI was translated to patients with acute stroke (1-24 h post-symptom onset), and assessments of APT contrast, perfusion, diffusion, disability and final infarct volume (23-92 days post-stroke) are reported. Healthy volunteers (n = 5) and patients (n = 10) with acute onset of symptoms (0-4 h, n = 7; uncertain onset <24 h, n = 3) were scanned with diffusion- and perfusion-weighted MRI, fluid-attenuated inversion recovery (FLAIR) and CEST. Traditional asymmetry and a Lorentzian-based APT index were calculated in the infarct core, at-risk tissue (time-to-peak, TTP; lengthening) and final infarct volume. On average (mean ± standard deviation), control white matter APT values (asymmetry, 0.019 ± 0.005; Lorentzian, 0.045 ± 0.006) were not significantly different (p > 0.05) from APT values in normal-appearing white matter (NAWM) of patients (asymmetry, 0.022 ± 0.003; Lorentzian, 0.048 ± 0.003); however, ischemic regions in patients showed reduced (p = 0.03) APT effects compared with NAWM. Representative cases are presented, whereby the APT contrast is compared quantitatively with contrast from other imaging modalities. The findings vary between patients; in some patients, a trend for a reduction in the APT signal in the final infarct region compared with at-risk tissue was observed, consistent with tissue acidosis. However, in other patients, no relationship was observed in the infarct core and final infarct volume. Larger clinical studies, in combination with focused efforts on sequence development at clinically available field strengths (e.g. 3.0 T), are necessary to fully understand the potential of APT imaging for guiding the hyperacute management of patients. Copyright © 2013 John Wiley & Sons, Ltd.
Article
The Stroke Imaging Research (STIR) Group, the American Society of Neuroradiology, and the Foundation of the American Society of Neuroradiology sponsored a series of working group meetings >12 months, with the final meeting occurring during the Stroke Treatment Academy Industry Roundtable (STAIR) on March 9 to 10, 2013, in Washington, DC. This process brought together vascular neurologists, neuroradiologists, neuroimaging research scientists, members of the National Institute of Neurological Disorders and Stroke, industry representatives, and members of the US Food and Drug Administration to discuss stroke imaging research priorities, especially in the light of the recent negative results of acute stroke clinical trials that tested the concept of penumbral imaging selection. The goal of this process was to propose a research roadmap for the next 5 years. STIR recommendations include (1) the use of standard terminology, aligned with the National Institute of Neurological Disorders and Stroke Common Data Elements; (2) a standardized imaging assessment of revascularization in acute ischemic stroke trials, including a modified Treatment In Cerebral Ischemia (mTICI) score; (3) a standardized process to assess whether ischemic core and penumbral imaging methods meet the requirements to be considered as an acceptable selection tool in acute ischemic stroke trials; (4) the characteristics of a clinical and imaging data repository to facilitate the development and testing process described in recommendation no. 3; (5) the optimal study design for a clinical trial to evaluate whether advanced imaging adds value in selecting acute ischemic stroke patients for revascularization therapy; and (6) the structure of a stroke neuroimaging network to implement and coordinate the recommendations listed above. All of these recommendations pertain to research, not to clinical care. STIR recommends the use of a standard terminology in compliance with the Common Data Elements developed by National Institute of Neurological Disorders and Stroke (http://www.commondataelements.ninds.nih.gov/stroke.aspx#tab=Data_Standards).1 …